구강편평상피암종에서 DCC 유전자의 역할
Role of DCC(Deleted in Colorectal Cancer) Gene in Oral Squamous Cell Carcinoma
0
조회
0
다운로드
0
인용
0
참고문헌
초록
Abstract
Chromosome 18q alteration plays a key role in colorectal tumorigenesis, and loss of heterozygosity at 18q is associated with a poor prognosis in colon cancer. DCC(Deleted in Colorectal Cancer) is a putative tumor- suppressor gene at 18q21 that encodes a transmembrane protein with structural similarity to neural cell adhesion molecule that is involved in both epithelial and neuronal cell differentiation. DCC is implicated in regulation of cell growth, survival and proliferation. Thus, tumor progression in squamous cell carcinoma, stomach cancer, colorectal cancer correlates with downregulation of DCC expression. The mechanism for DCC suppression is associated with hypermethylation of the DCC gene promoter region. Hence, the goal of this study is to identify the promoter methylation responsible for the down-regulation of DCC expression in oral squamous cell carcinoma. 12 of tissue specimens for the study are excised and gathered from 12 patients who are diagnosed as SCC in department of OMS, dental hospital, dankook university. To find expression of DCC in each tissue samples, immunohistochemical staining, RT-PCR gene analysis and methylation specific PCR are processed. The results are as follows. 1. In the DCC gene RT-PCR analysis, 5(41.6%) of 12 specimens of oral squamous cell carcinoma did not expressed DCC gene. 2. In the promoter methylation specific PCR analysis, 5(41.6%) of 12 specimens showed promoter methylation of DCC gene. 3. In the immunohistochemical staining of poor differentiated and invasive oral squamous cell carcinoma, loss of DCC expression was observed. These findings suggest that methylation of the DCC gene may play a role in loss of gene expression in invasive oral squamous cell carcinoma.
참고문헌 (45)
- 강정훈, "원발성 및 전이성 구강편평상피세포암종 세포주에서 p21 및 p73 mRNA 발현에 관한 연구", 대한구강악안면외과학회지, 27, pp.483~490 (2001)
- Hiyama T, "Second primary cancer following laryngeal cancer with special reference to smoking habits", Jpn J Cancer Res, 83, pp.334~339 (1992)
- Morita M, "Multiple occurrence of carcinoma in the upper aerodigestive tract associated with esophageal cancer: reference to smoking, drinking and family history", Int J Cancer, 58, pp.207~210 (1994)
- Vogelstein B, "Genetic alterations during colorectal tumor development", N Engl J Med, 319, pp.525~532 (1988)
- Fearon ER, "Identification of a chromosome 18q gene that is altered in colorectal cancers", Science, 247, pp.49~56 (1990)
- Cho KR, "Linking tumor suppressor genes and altered cell surface interactions in cancer", Eur J Cancer, 31A, pp.1055~1065 (1995)
- Shibata D, "The DCC protein and prognosis in colorectal cancers", N Engl J Med, 335, pp.1727~1732 (1996)
- Carethers JM, "The cellular and molecular pathogenesis of colorectal cancer", Gastroentero Clin North Am, 24, pp.737~754 (1997)
- Roesler J, "Tumor suppressor activity of neural cell adhesion molecule in colon carcinoma", Am J Surg, 174, pp.251~257 (1997)
- Fearon ER, "A genetic model for colorectal tumorigenesis", Cell, 61, pp.759~767 (1990)
- Tanaka K, "Suppression of tumorigenicity in human colon carcinoma cells by introduction of normal chromosome 5 or 18", Nature, 349, pp.340~342 (1991)
- Cho KR, "The DCC gene - structural analysis and mutations in colorectal carcinomas", Genomics, 19, pp.525~531 (1994)
- Forcet C, "The dependence receptor DCC(deleted in colorectal cancer) defines an alternative mechanism for caspase activation", Proc Natl Acad Sci USA, 98, pp.3416~3421 (2001)
- Lawlor KG, "Persistent expression of the tumor suppressor gene DCC is essential for neuronal differentiation", Cell Growth Differ, 3, pp.609~616 (1992)
- Hedrick L, "The DCC gene product in cellular differentiation and colorectal tumorigenesis", Genes Dev, 8, pp.1174~1183 (1994)
- Serafini T, "The netrins define a family of axon outgrowth-promoting proteins homologous to C. elegans UNC-6", Cell, 78(3), pp.409~424 (1994)
- Kennedy TE, "Netrins are diffusible chemotropic factors for commissural axons in the embryonic spinal cord", Cell, 78(3), pp.425~435 (1994)
- Oster SF, "Ganglion cell axon pathfinding in the retina and optic nerve", Semin. Cell Dev. Biol, 15, pp.125~136 (2004)
- Klingelhutz AJ, "The DCC gene suppresses the malignant phenotype of transformed human epithelial cells", Oncogene, 10, pp.1581~1586 (1995)
- Kato H, "Suppressed tumorigenicity of human endometrial cancer cells by the restored expression of the DCC gene", Br J Cancer, 82, pp.459~466 (2000)
- Velcich A, "Altered phenotype of HT29 colonic adenocarcinoma cells following expression of the DCC gene", Oncogene, 18, pp.2599~2606 (1999)
- Sato K, "Frequent loss of expression without sequence mutations of the DCC gene in primary gastric cancer", Br J Cancer, 85, pp.199~203 (2001)
- Arakawa H, "Netrin-1 and its receptors in tumorigenesis", Nat Rev Cancer, 4, pp.978~987 (2004)
- Mehlen P, "Role of the dependence receptor DCC in colorectal cancer pathogenesis", J Clin Oncol, 22, pp.3420~3428 (2004)
- Herman JG, "Gene silencing in cancer in association with promoter hypermethylation", N Engl J Med, 349(2042)통권 : 2044 (2003)
- Miyamoto K, "Identification of 20 genes aberrantly methylated in human breast cancers", Int J Cancer, 116, pp.407~414 (2005)
- Tamura G, "Promoter methylation status of tumor suppressor and tumor-related genes in neoplastic and non-neoplastic gastric epithelia", Histol Histopathol, 19, pp.221~228 (2004)
- Wolf P, "O6-methylguanine-DNA methyltransferase promoter hypermethylation shifts the p53 mutational spectrum in non-small cell lung cancer", Cancer Res, 61, pp.8113~8117 (2001)
- Nakamura M, "Promoter methylation of the DNA repair gene MGMT in astrocytomas is frequently associated with G:CA:T mutations of the TP 53 tumor suppressor gene", Carcinogenesis, 22, pp.1715~1719 (2001)
- Esteller M, "Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis", Cancer Res, 60, pp.2368~2371 (2000)
- Esteller M, "Promoter hypermethylation of the DNA repair gene O6-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis", Cancer Res, 61, pp.4689~4692 (2001)
- Oue N, "Promoter hypermethylation of MGMT is associated with protein loss in gastric carcinoma", Int J Cancer, 93, pp.805~809 (2001)
- Zhang L, "Inactivation of DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relation to p53 mutations in esophageal squamous cell carcinoma", Carcinogenesis, 24, pp.1039~1044 (2003)
- Yamashita K, "Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma", Cancer Cell, 2, pp.485~495 (2002)
- Ogi K, "Aberrant methylation of multiple genes and clinicopathological features in oral squamous cell carcinoma", Clin Cancer Res, 8, pp.3164~3171 (2002)
- Chuong CM, "cDCC(chicken homologue to a gene deleted in colorectal carcinoma) is an epithelial adhesion molecule expressed in the basal cells and involved in epithelial-mesenchymal interaction", Dev Biol, 164, pp.383~387 (1994)
- Parkin DM, "Global cancer statistics in the year 2000", Lancet Oncol, 2, pp.533~543 (2001)
- Mork J, "Forty years of monitoring head and neck cancer in Norwayno good news", Anticancer Res, 18, pp.3705~3708 (1998)
- Forastiere A, "Head and neck cancer", N Engl J Med, 345, pp.1890~1900 (2001)
- Lippman SM, "Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early-stage disease", Int J Radiat Oncol Biol Phys, 17, pp.691~694 (1989)
- Brian L, "Molecular Biology and Clinical Behavior of Oral Cancer", Oral Maxillofacial Surg Clin N Am, 18, pp.483~491 (2006)
- Fazeli A, "Phenotype of mice lacking functional Deleted in colorectal cancer (DCC) gene", Nature, 386, pp.796~804 (1997)
- Hahn SA, "DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1", Science, 271, pp.350~353 (1996)
- Carvalho A, "Deleted in colorectal cancer is a putative conditional tumour suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma", Cancer Res, 66, pp.9401~9407 (2006)
- Ishii T, "Oesophageal squamous cell carcinoma may develop within a background of accumulating DNA methylation in normal and dysplastic mucosa", Gut, 56, pp.13~19 (2007)
